Although Multiple Sclerosis (MS) is an autoimmune multifactorial disease with unknown etiology, various genetic and environmental factors are known to contribute to the pathogenesis of the disease.
OBJECTIVE:
Recent studies have confirmed that the suppressive function of regulatory T cells (T (reg)) is impaired in MS patients and that the FOXP3 gene is a crucial transcription factor in the regulation of CD4+CD25+FOXP3+ Treg cells. Polymorphisms in the promoter region of the FOXP3 gene may alter the gene expression level and, therefore, contribute to the disease susceptibility.
METHODS:
The present study aimed to investigate the possible association between single nucleotide polymorphisms (SNPs) rs3761548 and rs2232365 in the FOXP3 gene and predisposition to MS. We conducted a case-control study on 410 patients with sporadic MS and 446 healthy controls. Genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP).
RESULTS:
Significant differences in distribution of both rs3761548 and rs2232365 A allele were found in MS patients in comparison to controls. Haplotype frequencies were also different among the studied groups. The A-A and C-G haplotype blocks showed a significant difference between case and controls.
CONCLUSION:
we have provided further evidence for the association between genetic variations and haplotypes in FOXP3 and MS in Iranian population.
GiovannoniG. and EbersG., Multiple sclerosis: The environment and causation, Current Opinion in Neurology20(3) (2007), 261-268.
2.
GoldenbergM.M., Multiple sclerosis review, Pharmacy and Therapeutics37(3) (2012), 175.
3.
PellegrinoP. et al., Efficacy of vaccination against influenza in patients with multiple sclerosis: The role of concomitant therapies, Vaccine32(37) (2014), 4730-4735.
4.
KrementsovD.N. et al., Studies in experimental autoimmune encephalomyelitis do not support developmental bisphenol A exposure as an environmental factor in increasing multiple sclerosis risk, Toxicological Sciences135(1) (2013), 91-102.
5.
SawcerS., FranklinR.J. and BanM., Multiple sclerosis genetics, The Lancet Neurology13(7) (2014), 700-709.
6.
TaheriM. et al., TRAIL gene expression analysis in multiple sclerosis patients, Human Antibodies (2016), 1-6.
7.
HamedaniS.Y. et al., Up regulation of MMP9 gene expression in female patients with multiple sclerosis, Human Antibodies, (2016), 1-6.
8.
MazdehM. et al., HLA genes as modifiers of response to IFN-β -1a therapy in relapsing-remitting multiple sclerosis, Pharmacogenomics17(5) (2016), 489-498.
9.
HuanJ. et al., Decreased FOXP3 levels in multiple sclerosis patients, Journal of Neuroscience Research81(1) (2005), 45-52.
10.
PraksovaP. et al., Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations, Journal of the Neurological Sciences319(1) (2012), 18-23.
11.
Schneider-HohendorfT. et al., Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis, European Journal of Immunology40(12) (2010), 3581-3590.
12.
FontenotJ.D., GavinM.A. and RudenskyA.Y., Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells, Nature Immunology4(4) (2003), 330-336.
13.
HoriS., NomuraT. and SakaguchiS., Control of regulatory T cell development by the transcription factor Foxp3, Science299(5609) (2003), 1057-1061.
14.
FontenotJ.D. and RudenskyA.Y., A well adapted regulatory contrivance: Regulatory T cell development and the forkhead family transcription factor Foxp3, Nature Immunology6(4) (2005), 331-337.
15.
SakaguchiS. et al., Regulatory T cells and immune tolerance, Cell133(5) (2008), 775-787.
16.
SakaguchiS. et al., FOXP3+ regulatory T cells in the human immune system, Nature Reviews Immunology10(7) (2010), 490-500.
17.
BennettC.L. et al., The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3, Nature Genetics27(1) (2001).
18.
HaasJ. et al., Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis, The Journal of Immunology179(2) (2007), 1322-1330.
19.
Pacheco-GonzalezR. et al., Analysis of FOXP3 gene in children with allergy and autoimmune diseases, Allergologia Et Immunopathologia44(1) (2016), 32-40.
20.
KatohH., ZhengP. and LiuY., FOXP3: Genetic and epigenetic implications for autoimmunity, Journal of Autoimmunity41 (2013), 72-78.
21.
ChangX., ZhengP. and LiuY., FoxP3: A genetic link between immunodeficiency and autoimmune diseases, Autoimmunity Reviews5(6) (2006), 399-402.
22.
SambucciM. et al., Is there a correlation between CD39+ CD25+ T lymphocytes and Foxp3 isoforms in multiple sclerosis? Journal of Neuroimmunology275(1) (2014), 208.
23.
VenkenK. et al., Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+ CD25+ regulatory T-cell function and FOXP3 expression, Journal of Neuroscience Research83(8) (2006), 1432-1446.
24.
KumarM. et al., CD4+ CD25+ FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis, Journal of Neuroimmunology180(1) (2006), 178-184.
25.
GawlikB.B. and HaflerD.A., Regulatory T Cells in MS, in: Multiple Sclerosis Immunology Springer, (2013), 27-47.
26.
HanelS.A. et al., Novel and functional regulatory SNPs in the promoter region of FOXP3 gene in a Gabonese population, Immunogenetics63(7) (2011), 409-415.
27.
OwenC.J. et al., Genetic association studies of the FOXP3 gene in Graves' disease and autoimmune Addison's disease in the United Kingdom population, Journal of Molecular Endocrinology37(1) (2006), 97-104.
28.
LinY. et al., Association of single-nucleotide polymorphisms in FOXP3 gene with systemic lupus erythematosus susceptibility: A case - control study, Lupus20(2) (2011), 137-143.
29.
RuanY., ZhangY. and ZhangL., [Association between single-nucleotide polymorphisms of key genes in T regulatory cells signaling pathways and the efficacy of allergic rhinitis immune therapy], Chinese Journal of Otorhinolaryngology Head and Neck Surgery51(1) (2016), 34-42.
30.
JafarzadehA. et al., Circulating levels of interleukin-35 in patients with multiple sclerosis: Evaluation of the influences of FOXP3 gene polymorphism and treatment program, Journal of Molecular Neuroscience55(4) (2015), 891-897.
31.
EtemadifarM. et al., Epidemiology of multiple sclerosis in Iran: A systematic review, European Neurology70(5-6) (2013), 356-363.
32.
TintoréM. et al., Isolated demyelinating syndromes: Comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis, American Journal of Neuroradiology21(4) (2000), 702-706.
33.
McDonaldW.I. et al., Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis, Annals of Neurology50(1) (2001), 121-127.
34.
MillerD. et al., Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: Concerted action guidelines, Journal of Neurology, Neurosurgery & Psychiatry54(8) (1991), 683-688.
35.
SoléX. et al., SNPStats: A web tool for the analysis of association studies, Bioinformatics22(15) (2006), 1928-1929.
36.
BarrettJ.C. et al., Haploview: Analysis and visualization of LD and haplotype maps, Bioinformatics21(2) (2005), 263-265.
37.
GovermanJ.M., Immune tolerance in multiple sclerosis, Immunological Reviews241(1) (2011), 228-240.
38.
SongQ. et al., An association study of single nucleotide polymorphisms of the FOXP3 intron-1 and the risk of Psoriasis vulgaris, Indian J Biochem Biophys49(1) (2012), 25-35.
39.
D'amicoF. et al., Genetic polymorphisms of FOXP3 in Italian patients with systemic sclerosis, Immunology Letters152(2) (2013), 109-113.
40.
ZhangL. et al., Genetic association study of FOXP3 polymorphisms in allergic rhinitis in a Chinese population, Human Immunology70(11) (2009), 930-934.
41.
LeeH.J. et al., Immunogenetics of autoimmune thyroid diseases: A comprehensive review, Journal of Autoimmunity64 (2015), 82-90.
42.
Paradowska-GoryckaA. et al., Genetic polymorphisms of Foxp3 in patients with rheumatoid arthritis, The Journal of Rheumatology42(2) (2015), 170-180.
43.
ShenZ. et al., Intron-1 rs3761548 is related to the defective transcription of Foxp3 in psoriasis through abrogating E47/c-Myb binding, Journal of Cellular and Molecular Medicine14(1-2) (2010), 226-241.
44.
WuZ. et al., Association between functional polymorphisms of Foxp3 gene and the occurrence of unexplained recurrent spontaneous abortion in a Chinese Han population, Clinical and Developmental Immunology2012 (2011).
45.
FontenotJ.D. et al., A function for interleukin 2 in Foxp3-expressing regulatory T cells, Nature Immunology6(11) (2005), 1142-1151.
46.
D'CruzL.M. and KleinL., Development and function of agonist-induced CD25+ Foxp3+ regulatory T cells in the absence of interleukin 2 signaling, Nature Immunology6(11) (2005), 1152-1159.
47.
YagiH. et al., Crucial role of FOXP3 in the development and function of human CD25+ CD4+ regulatory T cells, International Immunology16(11) (2004), 1643-1656.
48.
EftekharianM.M. et al., RAR-related orphan receptor A (RORA): A new susceptibility gene for multiple sclerosis, J Neurol Sci369 (2016), 259-262.
